aTyr Pharma Inc (LIFE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

1600 FARADAY AVE CARLSBAD, CA 92008

aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in inflammatory lung diseases.

Data as of 2021-05-08 11:40:02 -0400
Market Cap61.163 Million Shares Outstanding16.011 Million Avg 30-day Volume422.012 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.01 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.94563 52-week High/Low8.33 / 2.93 Next Earnings Date2021-05-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for these stocks instead?

View SEC Filings from LIFE instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 24 26 -7.69% 10 (0.6%) 11 (0.68%) -9.09%
13F shares: 5.894 Million 5.766 Million 2.23% 1.908 Million 2.262 Million -15.65%
% Ownership 57.8694 57.6102 0.45% 18.7289 22.5988 -17.12%
New Positions: 5 4 25.0% 3 2 50.0%
Increased Positions 7 10 -30.0% 2 6 -66.67%
Closed Positions 7 4 75.0% 4 3 33.33%
Reduced Positions 4 2 100.0% 3 1 200.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LIFE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LIFE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHIMMEL PAUL

  • Director
1,428 2021-04-28 2

CLARKE JOHN K

  • Director
1,428 2021-04-28 3

COUGHLIN TIMOTHY

  • Director
1,428 2021-04-28 1

GROSS JANE A

  • Director
1,428 2021-04-28 1

LUCAS SVETLANA

  • Director
1,428 2021-04-28 1

SHUKLA SANJAY PRESIDENT AND CEO

  • Officer
  • Director
8,298 2021-02-06 6

BROADFOOT JILL MARIE CHIEF FINANCIAL OFFICER

  • Officer
9,833 2021-02-06 4

DENYES NANCY GENERAL COUNSEL

  • Officer
0 2021-02-04 2

HATFIELD JEFFREY S.

  • Director
0 2020-05-06 0

MENDLEIN JOHN

  • Director
0 2019-05-08 0

BLAIR JAMES C

  • Director
0 2019-05-08 0

AMANULLAH ASHRAF SEE REMARKS

  • Officer
No longer subject to file 2018-05-31 0

NASHAT AMIR

  • Director
0 2018-05-15 0

ECOR1 CAPITAL FUND QUALIFIED, L.P.

  • 10% Owner
No longer subject to file 2018-05-14 0

BLACKBURN STAN

  • SEE REMARKS
11,954 2018-03-20 0

BLAKE JOHN T SENIOR VICE PRESIDENT, FINANCE

  • Officer
1,932 2018-02-06 0

KING DAVID JOHN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-02-06 0

AKKARAJU SRINIVAS

  • Director
0 2017-05-09 0

GOLDBERG MARK ALAN

  • Director
0 2017-05-09 0

RAVINDRAN SANUJ K. CHIEF BUSINESS OFFICER

  • Officer
0 2017-02-07 0

MATSUOKA GROVE SEE REMARKS

  • Officer
0 2017-02-07 0

CUBITT ANDREW VP, PRODUCT PROTECTION

  • Officer
0 2016-09-13 0

FALBERG KATHRYN E

  • Director
0 2016-05-24 0

BLACKBURN KELLY VP, CLINICAL AFFAIRS

  • Officer
0 2016-03-28 0

CHRZANOWSKI HOLLY D. SEE REMARKS

  • Officer
0 2016-01-27 0

MCKEW JOHN C. VP, RESEARCH

  • Officer
0 2016-01-27 0

ASHLOCK MELISSA A. SEE REMARKS

  • Officer
0 2016-01-27 0

GRAHAM MARCY SEE REMARKS

  • Officer
0 2016-01-04 0

RAMSDELL FRED VP, IMMUNOLOGY

  • Officer
0 2015-10-01 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2015-05-12 0

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

  • 10% Owner
No longer subject to file 2015-05-12 0

ALTA PARTNERS VIII, L.P.

ALTA PARTNERS MANAGEMENT VIII, LLC

JANNEY DANIEL

CHAMPSI FARAH

NOHRA GUY P

  • 10% Owner
No longer subject to file 2015-05-12 0

CHP II LP

CHP II MANAGEMENT, LLC

HULL BRANDON H

PARK JOHN JOSEPH

  • 10% Owner
No longer subject to file 2015-05-12 0

DP VIII ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • Director
  • 10% Owner
13,414 2015-05-12 0

DOMAIN PARTNERS VIII, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • Director
  • 10% Owner
1,807,820 2015-05-12 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

HEALY JAMES

POWELL MICHAEL

MEHRA ANAND

  • 10% Owner
No longer subject to file 2015-05-12 0

CHEREAU FREDERIC COO & PRESIDENT

  • Officer
12,867 2015-05-06 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • Director
  • 10% Owner
12,572 2015-05-06 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

HEALY JAMES

POWELL MICHAEL

AKKARAJU SRINIVAS

MEHRA ANAND

  • 10% Owner
0 2015-05-06 0

WEINER DAVID M. CHIEF MEDICAL OFFICER

  • Officer
5,028 2015-05-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CLARKE JOHN K - Director

2021-04-29 20:02:55 -0400 2021-04-28 A 1,428 a 1,428 direct

COUGHLIN TIMOTHY - Director

2021-04-29 20:06:39 -0400 2021-04-28 A 1,428 a 1,428 direct

LUCAS SVETLANA - Director

2021-04-29 20:11:17 -0400 2021-04-28 A 1,428 a 1,428 direct

GROSS JANE A - Director

2021-04-29 20:08:33 -0400 2021-04-28 A 1,428 a 1,428 direct

SCHIMMEL PAUL - Director

2021-04-29 20:13:17 -0400 2021-04-28 A 1,428 a 1,428 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ATYR PHARMA INC LIFE 2021-05-14 22:15:03 UTC -0.7469 0.7969 85000
ATYR PHARMA INC LIFE 2021-05-14 21:45:03 UTC -0.7469 0.7969 85000
ATYR PHARMA INC LIFE 2021-05-14 21:15:03 UTC -0.7469 0.7969 85000
ATYR PHARMA INC LIFE 2021-05-14 20:45:03 UTC -0.748 0.798 85000
ATYR PHARMA INC LIFE 2021-05-14 20:15:04 UTC -0.748 0.798 85000
ATYR PHARMA INC LIFE 2021-05-14 19:45:02 UTC -0.748 0.798 85000
ATYR PHARMA INC LIFE 2021-05-14 19:15:03 UTC -0.748 0.798 85000
ATYR PHARMA INC LIFE 2021-05-14 18:45:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 18:15:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 17:45:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 17:15:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 16:45:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 16:15:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 15:45:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 15:15:02 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 14:45:04 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 14:15:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 13:45:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 13:15:03 UTC -0.7498 0.7998 85000
ATYR PHARMA INC LIFE 2021-05-14 12:45:03 UTC -0.7498 0.7998 80000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund LIFE -1300.0 shares, $-5785.0 2021-03-31 N-PORT

Elevate your investments